Literature DB >> 9879941

Ecological and physiological studies on large intestinal bacteria in relation to production of hydrolytic and reductive enzymes involved in formation of genotoxic metabolites.

A J McBain1, G T Macfarlane.   

Abstract

Several hydrolytic and reductive bacterial enzymes (beta-glucuronidase, GN; beta-glucosidase, GS; arylsulphatase, AS; azoreductase, AR; nitroreductase, NR) involved in production of mutagenic or genotoxic metabolites were measured in human colonic contents. Cell-associated AS and extracellular GS were approximately twice as high in the distal colon compared with the proximal bowel, while AR changed little throughout the gut. Measurements of these enzymes in faeces from seven healthy donors confirmed that the majority were cell-associated, and demonstrated high levels of inter-individual variability. NR decreased four-fold between the proximal and distal colon while extracellular GN was reduced by 50%. Most probable number (MPN) analysis on faeces obtained from six healthy donors showed that counts of intestinal bacteria producing GS and AR were c. 10(10) and 10(11)/g, respectively, in all samples tested. Numbers of GN- and AS-forming organisms were between two and three orders of magnitude lower. Inter-individual carriage rates of bacterial populations synthesising NR were highly variable. Screening of 20 pure cultures of intestinal bacteria, belonging to six different genera, showed that Bacteroides ovatus, in particular, synthesised large amounts of GS, whereas B. fragilis, B. vulgatus and Bifidobacterium pseudolongum formed the highest cell-associated levels of GN. In general, bifidobacteria and Lactobacillus acidophilus did not produce significant amounts of AR. All five clostridia studied (Clostridium bifermentans, C. septicum, C. perfringens, C. sporogenes and C. butyricum) produced NR and AR, as did the bacteroides (B. fragilis, B. ovatus and B. vulgatus). Escherichia coli and C. perfringens formed large amounts of NR. Levels of AS production were invariably low and few of the organisms screened synthesised this enzyme. In-vitro studies investigating the effect of intestinal transit time on enzyme production, in a three-stage (V1-V3) continuous culture model of the colon operated at system retention times (R) of either 31.1 or 68.4 h, showed that specific activities of GS were up to four-fold higher (V3) at R = 31.1 h. Bacteriological analysis demonstrated that representative populations of colonic micro-organisms were maintained in the fermentation system, and indicated that changes in GS activity were not related to numbers of the predominant anaerobic or facultative anaerobic species within the model, but were explainable on the basis of substrate-induced modulation of bacterial metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9879941     DOI: 10.1099/00222615-47-5-407

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  44 in total

1.  Intestinal bacterial metabolism and anti-complement activities of three major components of the seeds of Entada phaseoloides.

Authors:  Shihua Xing; Mengyue Wang; Ying Peng; Yuqiong Dong; Xiaobo Li
Journal:  J Nat Med       Date:  2014-11-15       Impact factor: 2.343

2.  Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men.

Authors:  Ellen G H M van den Heuvel; Daniel Wils; Wilrike J Pasman; Marie-Hélène Saniez; Alwine F M Kardinaal
Journal:  Eur J Nutr       Date:  2005-02-09       Impact factor: 5.614

3.  Composition and metabolic activities of bacterial biofilms colonizing food residues in the human gut.

Authors:  Sandra Macfarlane; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

Review 4.  Microbiome and malignancy.

Authors:  Claudia S Plottel; Martin J Blaser
Journal:  Cell Host Microbe       Date:  2011-10-20       Impact factor: 21.023

Review 5.  Colorectal Cancer: Why Does Side Matter?

Authors:  Claire Gallois; Simon Pernot; Aziz Zaanan; Julien Taieb
Journal:  Drugs       Date:  2018-06       Impact factor: 9.546

Review 6.  The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.

Authors:  Maryann Kwa; Claudia S Plottel; Martin J Blaser; Sylvia Adams
Journal:  J Natl Cancer Inst       Date:  2016-04-22       Impact factor: 13.506

7.  Low prevalence of Clostridium septicum fecal carriage in an adult population.

Authors:  Fatos A Kopliku; Alyxandria M Schubert; Jill Mogle; Patrick D Schloss; Vincent B Young; David M Aronoff
Journal:  Anaerobe       Date:  2014-12-03       Impact factor: 3.331

8.  Bioactivity and bioavailability of ginsenosides are dependent on the glycosidase activities of the A/J mouse intestinal microbiome defined by pyrosequencing.

Authors:  Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu
Journal:  Pharm Res       Date:  2012-12-20       Impact factor: 4.200

Review 9.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

10.  Impact of ubiquitous inhibitors on the GUS gene reporter system: evidence from the model plants Arabidopsis, tobacco and rice and correction methods for quantitative assays of transgenic and endogenous GUS.

Authors:  Simone Fior; Paolo D Gerola
Journal:  Plant Methods       Date:  2009-12-30       Impact factor: 4.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.